Clinical Trial Update: Influence of Neoadjuvant Therapy on the Resectability of Hepatic Metastases From Colorectal Cancers [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating whether neoadjuvant therapy can influence the resectability of liver metastases in colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN